메뉴 건너뛰기




Volumn 7, Issue 6, 2012, Pages 943-948

Cholesterol synthesis, cholesterol absorption, and mortality in hemodialysis patients

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTANOL; CHOLESTEROL; LATHOSTEROL;

EID: 84862194892     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.05170511     Document Type: Article
Times cited : (47)

References (17)
  • 3
    • 0042073221 scopus 로고    scopus 로고
    • Traditional cardiac risk factors in individuals with chronic kidney disease
    • Uhlig K, Levey AS, Sarnak MJ: Traditional cardiac risk factors in individuals with chronic kidney disease. SeminDial 16: 118-127, 2003
    • (2003) SeminDial , vol.16 , pp. 118-127
    • Uhlig, K.1    Levey, A.S.2    Sarnak, M.J.3
  • 5
    • 78650184434 scopus 로고    scopus 로고
    • Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
    • Sharp Collaborative G. Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease. Am Heart J 160: 785-794. 2010
    • (2010) Am Heart J , vol.160 , pp. 785-794
    • Sharp Collaborative, G.1
  • 6
    • 22344458137 scopus 로고    scopus 로고
    • Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
    • German Diabetes and Dialysis Study Investigators
    • Wanner C, Krane V, März W, Olschewski M, Mann JF, Ruf G, Ritz E; German Diabetes and Dialysis Study Investigators: Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl JMed 353: 238-248, 2005
    • (2005) N Engl JMed , vol.353 , pp. 238-248
    • Wanner, C.1    Krane, V.2    März, W.3    Olschewski, M.4    Mann, J.F.5    Ruf, G.6    Ritz, E.7
  • 7
    • 78449281377 scopus 로고    scopus 로고
    • Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials
    • Cholesterol Treatment Trialists' (CTT) Collaboration
    • Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, Peto R, Barnes EH, Keech A, Simes J, Collins R; Cholesterol Treatment Trialists' (CTT) Collaboration: Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 376: 1670-1681, 2010
    • (2010) Lancet , vol.376 , pp. 1670-1681
    • Baigent, C.1    Blackwell, L.2    Emberson, J.3    Holland, L.E.4    Reith, C.5    Bhala, N.6    Peto, R.7    Barnes, E.H.8    Keech, A.9    Simes, J.10    Collins, R.11
  • 9
    • 0025156823 scopus 로고
    • Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selectedmale population
    • Miettinen TA, Tilvis RS, Kesäniemi YA: Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selectedmale population. AmJ Epidemiol 131: 20-31, 1990
    • (1990) AmJ Epidemiol , vol.131 , pp. 20-31
    • Miettinen, T.A.1    Tilvis, R.S.2    Kesäniemi, Y.A.3
  • 10
    • 0032507494 scopus 로고    scopus 로고
    • Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian simvastatin survival study. Finnish 4S Investigators
    • Miettinen TA, Gylling H, Strandberg T, Sarna S: Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian simvastatin survival study. Finnish 4S Investigators. BMJ 316: 1127-1130, 1998
    • (1998) BMJ , vol.316 , pp. 1127-1130
    • Miettinen, T.A.1    Gylling, H.2    Strandberg, T.3    Sarna, S.4
  • 11
    • 30044443681 scopus 로고    scopus 로고
    • Cholestanol: A serum marker to guide LDL cholesterol-lowering therapy
    • Hoenig MR, Rolfe BE, Campbell JH: Cholestanol: A serum marker to guide LDL cholesterol-lowering therapy. Atherosclerosis 184: 247-254, 2006
    • (2006) Atherosclerosis , vol.184 , pp. 247-254
    • Hoenig, M.R.1    Rolfe, B.E.2    Campbell, J.H.3
  • 13
    • 0242721947 scopus 로고    scopus 로고
    • Synthesis and absorption markers of cholesterol in serum and lipoproteins during a large dose of statin treatment
    • Miettinen TA, Gylling H: Synthesis and absorption markers of cholesterol in serum and lipoproteins during a large dose of statin treatment. Eur J Clin Invest 33: 976-982, 2003
    • (2003) Eur J Clin Invest , vol.33 , pp. 976-982
    • Miettinen, T.A.1    Gylling, H.2
  • 15
    • 77953229699 scopus 로고    scopus 로고
    • Relationship between cholesterol synthesis and intestinal absorption is associated with cardiovascular risk
    • Weingärtner O, Lütjohann D, Böhm M, Laufs U: Relationship between cholesterol synthesis and intestinal absorption is associated with cardiovascular risk. Atherosclerosis 210: 362-365, 2010
    • (2010) Atherosclerosis , vol.210 , pp. 362-365
    • Weingärtner, O.1    Lütjohann, D.2    Böhm, M.3    Laufs, U.4
  • 16
    • 33644854296 scopus 로고    scopus 로고
    • Dyslipidemia of chronic renal failure: The nature, mechanisms, and potential consequences
    • Vaziri ND: Dyslipidemia of chronic renal failure: The nature, mechanisms, and potential consequences. Am J Physiol Renal Physiol 290: F262-F272, 2006
    • (2006) Am J Physiol Renal Physiol , vol.290
    • Vaziri, N.D.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.